Sanderson Farms (NASDAQ: SAFM), National Steel Corporation (NYSE: SID), Juniper Networks (NASDAQ: JNPR), Healthways, Inc. (NASDAQ: HWAY) and The Ryland Group, Inc. (NYSE: RYL) upgraded by analysts.
Sanderson Farms (SAFM) was upgraded by JPMorgan Chase & Co. (NYSE:JPM) from an “Underweight” rating to a “Neutral” rating.
National Steel Corporation (SID) was upgraded by JPMorgan Chase & Co. from an “Underweight” rating to a “Neutral” rating.
Juniper Networks (JNPR) was upgraded by Morgan Keegan from a “Market Perform” rating to an “Outperform” rating. They have a price target of $27.00 on the company.
Healthways, Inc. (HWAY) was upgraded by JMP Securities from an “Underperform” rating to a “Market Perform” rating.
The Ryland Group, Inc. (RYL) was upgraded by Credit Suisse (NYSE:CS) from an “Underperform” rating to a “Neutral” rating.
Showing posts with label Healthways. Show all posts
Showing posts with label Healthways. Show all posts
Wednesday, August 24, 2011
Monday, May 16, 2011
Ratings on (HWAY) (AU) (HPJ) (KSS) Reiterated
Ratings on shares of Healthways (NASDAQ:HWAY), Anglogold (NYSE:AU), Hong Kong Highpower (NASDAQ:HPJ) and Kohl's (NYSE:KSS) reiterated by analysts.
FBR Capital reiterated an "Outperform" rating on Healthways (HWAY). They raised their price target on the company from $17 to $19.
HSBC Securities reiterated an "Overweight" rating on Anglogold (AU). They raised their price target on the company from $61 to $65.
Rodman & Renshaw reiterated a "Market Outperform" rating on Hong Kong Highpower (HPJ). They lowered their price target on the company from $7 to $4.
FBR Capital reiterated a "Market Perform" rating on Kohl's (KSS). They lowered their price target on the company from $58 to $55.
FBR Capital reiterated an "Outperform" rating on Healthways (HWAY). They raised their price target on the company from $17 to $19.
HSBC Securities reiterated an "Overweight" rating on Anglogold (AU). They raised their price target on the company from $61 to $65.
Rodman & Renshaw reiterated a "Market Outperform" rating on Hong Kong Highpower (HPJ). They lowered their price target on the company from $7 to $4.
FBR Capital reiterated a "Market Perform" rating on Kohl's (KSS). They lowered their price target on the company from $58 to $55.
Saturday, May 14, 2011
Ratings on (FCS) (HWAY) (ONNN) (SCHW) (URS) Reiterated
Ratings on shares of Fairchild Semiconductor (NYSE:FCS), Healthways Inc. (NASDAQ:HWAY), ON Semiconductor (NASDAQ:ONNN), Charles Schwab (NYSE:SCHW) and URS Corp. (NYSE:URS) were reiterated by analysts.
Deutsche Bank (NYSE:DB) reiterated a “hold” rating on Fairchild Semiconductor (FCS). They have a price target of $18 on the company.
FBR Capital Markets reiterated an “Outperform” rating on Healthways Inc. (HWAY). They have a price target of $19 on the company. Up from $17.
Deutsche Bank reiterated a “Buy” rating on ON Semiconductor (ONNN). They now have a price target of $15 on the company.
FBR Capital Markets reiterated a “Market Perform” rating on Charles Schwab (SCHW). They have a price target of $20 on the company.
FBR Capital Markets reiterated an “Outperform” rating on URS Corp. (URS). They have a price target of $60 on the company.
Deutsche Bank (NYSE:DB) reiterated a “hold” rating on Fairchild Semiconductor (FCS). They have a price target of $18 on the company.
FBR Capital Markets reiterated an “Outperform” rating on Healthways Inc. (HWAY). They have a price target of $19 on the company. Up from $17.
Deutsche Bank reiterated a “Buy” rating on ON Semiconductor (ONNN). They now have a price target of $15 on the company.
FBR Capital Markets reiterated a “Market Perform” rating on Charles Schwab (SCHW). They have a price target of $20 on the company.
FBR Capital Markets reiterated an “Outperform” rating on URS Corp. (URS). They have a price target of $60 on the company.
Friday, May 13, 2011
Price Targets on (CA) (FDX) (FL) (HPJ) (HWAY) Updated
Price targets on CA Tech (NYSE: CA), FedEx (NYSE: FDX), Foot Locker (NYSE: FL), Hong Kong Highpower (NYSE: HPJ) and Healthways, Inc. (NASDAQ: HWAY) were updated by analysts.
Needham & Company raised their price target on CA Tech (CA) from $27.00 to $29.00. They have a “buy” rating on the company.
Stifel Nicolaus raised their price target on FedEx (FDX) from $116.00 to $120.00.
Wedbush raised their price target on Foot Locker (FL) from $23.00 to $26.00.
Rodman & Renshaw cut their price target on Hong Kong Highpower (HPJ) from $7.00 to $4.00. They have an “outperform” rating on the company.
FBR Capital raised their price target on Healthways, Inc. (HWAY) from $17.00 to $19.00. They have an “outperform” rating on the company.
Needham & Company raised their price target on CA Tech (CA) from $27.00 to $29.00. They have a “buy” rating on the company.
Stifel Nicolaus raised their price target on FedEx (FDX) from $116.00 to $120.00.
Wedbush raised their price target on Foot Locker (FL) from $23.00 to $26.00.
Rodman & Renshaw cut their price target on Hong Kong Highpower (HPJ) from $7.00 to $4.00. They have an “outperform” rating on the company.
FBR Capital raised their price target on Healthways, Inc. (HWAY) from $17.00 to $19.00. They have an “outperform” rating on the company.
Thursday, December 16, 2010
Medco Health (NYSE:MHS), Healthways (Nasdaq:HWAY) Quality Systems (Nasdaq:QSII), Omnicell (Nasdaq:OMCL), Kindred Healthcare (NYSE:KND) FBR's Top Healt
FBR Capital released its healthcare services outlook for 2011 in various segments of the sector, and their favorites are Medco Health (NYSE:MHS), Healthways (Nasdaq:HWAY) Quality Systems (Nasdaq:QSII), Omnicell (Nasdaq:OMCL) and Kindred Healthcare (NYSE:KND).
FBR said, "Healthcare services remains an attractive area for investment in 2011 as strong momentum in the back half of 2010 is likely to be carried forward into the new year. Investors are in a better position in 2011 than they were in 2010 as utilization of services is more stable and healthcare reform is a reality. Assessing the impact of healthcare reform remains a difficult task, but at least there is less uncertainty than a year ago. Our focus tends to be on areas that have considerable benefits that help to drive demand for those services, and that has not changed. We are particularly bullish on the pharmacy benefit management (PBM) sector, as prospects remain bright and the industry is positioned to reap the benefits from the wave of branded drugs going off-patent. Healthcare IT investment appears to be seeing steady improvement, although we are unsure if this will be enough to satisfy the momentum investors, who have made this sector a favorite. We remain cautious on the post–acute care environment, as pricing pressure and regulatory uncertainty continue to weigh on valuations as investors try to determine a reasonable baseline from which these companies can grow. The potential for earnings growth exists, but obstacles still appear to be in the way of that growth.
"Positive on the PBM space...Our best long ideas for 2011 are Medco Health Solutions, Inc. (Outperform) for the large-cap space and Healthways Inc. (Outperform) for the small-cap space.
"Healthcare IT has time to prove its worth...Our best long idea for 2011 is Quality Systems, Inc. (Market Perform), while our best short idea is Omnicell, Inc. (Underperform), which we believe has little to no exposure to the benefits that are boosting the valuations of the healthcare IT space.
"2011 remains a challenge for the post–acute care space...Among our coverage universe, we are most bullish on Kindred Healthcare, Inc. (Market Perform), as the company has shown an ability to navigate difficult regulatory waters and challenging pricing environments in the past."
FBR said, "Healthcare services remains an attractive area for investment in 2011 as strong momentum in the back half of 2010 is likely to be carried forward into the new year. Investors are in a better position in 2011 than they were in 2010 as utilization of services is more stable and healthcare reform is a reality. Assessing the impact of healthcare reform remains a difficult task, but at least there is less uncertainty than a year ago. Our focus tends to be on areas that have considerable benefits that help to drive demand for those services, and that has not changed. We are particularly bullish on the pharmacy benefit management (PBM) sector, as prospects remain bright and the industry is positioned to reap the benefits from the wave of branded drugs going off-patent. Healthcare IT investment appears to be seeing steady improvement, although we are unsure if this will be enough to satisfy the momentum investors, who have made this sector a favorite. We remain cautious on the post–acute care environment, as pricing pressure and regulatory uncertainty continue to weigh on valuations as investors try to determine a reasonable baseline from which these companies can grow. The potential for earnings growth exists, but obstacles still appear to be in the way of that growth.
"Positive on the PBM space...Our best long ideas for 2011 are Medco Health Solutions, Inc. (Outperform) for the large-cap space and Healthways Inc. (Outperform) for the small-cap space.
"Healthcare IT has time to prove its worth...Our best long idea for 2011 is Quality Systems, Inc. (Market Perform), while our best short idea is Omnicell, Inc. (Underperform), which we believe has little to no exposure to the benefits that are boosting the valuations of the healthcare IT space.
"2011 remains a challenge for the post–acute care space...Among our coverage universe, we are most bullish on Kindred Healthcare, Inc. (Market Perform), as the company has shown an ability to navigate difficult regulatory waters and challenging pricing environments in the past."
Subscribe to:
Posts (Atom)